| EMA number | EMEA/H/C/000121 |
| ATC code | J05AB12 |
| Authorisation | 23 April 1997 |
| Withdrawn | 22 August 2014 |
| Revision | 21 |
Vistide is indicated for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction. Vistide should be used only when other agents are considered unsuitable.